Untitled Document
www.expresshealthcare.in INSIGHT INTO THE BUSINESS OF HEALTHCARE
June 2009  
Untitled Document
Sections

Market
Trade & Trends
Strategy
IT@Healthcare
Labwatch
Healthcare Life

Specials

In Imaging 2009
Criticare Frontiers 2009

Services
Subscribe/Renew
Archives/Search
Contact Us
Network Sites
Express Computer
Exp. Channel Business
Express Hospitality
Express TravelWorld
Express Pharma
Group Sites
ExpressIndia
Indian Express
Financial Express

Home - Strategy - Article

Spotlight

Seeking the 'Sweet' Truth

WHO collaborating centre for research, education and training in diabetes— MV Hospital for Diabetes, Chennai has been conducting some unique research projects in diabetes. Rita Dutta reports about the significance of some of the projects

With over 30 million diabetics, India bears the burden of being the 'diabetes capital' of the world. And the 'not-so-sweet' news is that many of the people with diabetes are developing multiple complications. In such a gloomy situation, it's heartening to know that MV Hospital for Diabetes, located at Royapuram in Chennai, has put diabetes research on its radar.

The MV Story

MV Hospital for Diabetes, which was started by late Dr M Viswanathan, began functioning as Vijaya Nursing Home in 1954. The name of the nursing home was Vijaya after its founders— Dr Viswanathan and his friend and surgeon Dr Jay Singh. It was only in 1971, that MV Hospital was founded. Today, the hospital has expanded to become a 100-bed unit and the reins of the hospital is in the hands of Dr Viswanathan's able son —renowned diabetologist Dr Vijay Viswanathan.

To promote diabetes research, Dr Viswanathan founded another organisation Diabetes Research Centre (DRC) under the Department of Science and Technology in 1972 from the premises of MV Hospital for Diabetes. However, the major boost in research occurred when the hospital was acknowledged as WHO's collaborating centre for diabetes research since 2002. Under this, the hospital organises awareness campaign, conducts screening programmes and provides training to doctors. The WHO sponsors fellows including doctors and nurses for training at the centre.

Community-based Research Projects


Special shoes for diabetics at MV Hospital

Childhood obesity: With an endeavour to arrest diabetes at an early age, MV Hospital has charted out a unique project targeting childhood obesity. Says Dr Shabana Tharkar, Head, Department of Epidemiology, MV Hospital, "Research suggests that in urban India, the prevalence of obesity among children and adolescence ranges from 8.5 to 29 per cent and 1.5 to 7.4 per cent, respectively. However, research data on behavioural intervention studies on children is sparse. Hence, a study was designed with the aim of assessing the impact of intensive intervention by lifestyle modification among obese children."

Started last year, the prevalence of childhood obesity was assessed in a sample size of 1,193 school children aged between 8-15 years. Three schools (two private and one corporation) were selected by stratified cluster-sampling technique. The prevalence rates were calculated using WHO-BMI for age percentile chart 2007. Regression analysis was done to determine risk factors associated with overweight. "The study found the prevalence of overweight was 12.1 per cent among children and 15.5 per cent among adolescents. Both overweight (22 per cent) and obesity (13.7 per cent) were higher among girls from affluent families. The mean anthropometric measurements, prevalence of overweight and obesity were higher among urban affluent children," says Dr Tharkar. The findings suggested the need for early intervention programme, targeting children from affluent society. Taking a cue from the findings, the hospital is conducting the second phase of the study, whereby a comparative study of two schools is being done. In one school, the hospital would go only once to create awareness about obesity and in another it would monitor the subjects every two months with lecture on dietary modifications and physical education. After two years, the study would compare both the schools to assess the impact of intervention.

"Severe hyperglycemia interferes with TB
treatment—causing delay in management
of the disease"

- Dr Vijay Viswanathan
Managing Director
MV Hospital for Diabetes

"A diabetic patient with hypertension spends 1.4 times more than a
diabetic without
hypertension"

- Dr Shabana Tharkar
Head, Department of Epidemiology
MV Hospital for Diabetes

Comparing COPS with GPs: To address the paucity of data on prevalence of metabolic syndrome and diabetics in different occupational categories in India, MV Hospital for Diabetes has conducted a study involving the policemen. The study, which was recently published in a paper in Volume 56- November 2008 edition of JAPI, aimed to determine the prevalence of metabolic syndrome and associated cardio vascular risk factors among police personnel and compare that with the General Population (GP). Two populations (719 men aged 30 and more from Chennai) with similar demography were selected for this study. Explains Dr Vijay Viswanathan, MD, MV Hospital, "The prevalence of metabolic syndrome was significantly higher among police as compared to GP. The police had a higher prevalence of individual cardio metabolic abnormalities and diabetes in comparison with GP."

In another study, north and central police stations of Chennai were included in the study for a span of two years. "Motivation and re-inforcements are done once in three months regarding lifestyle modification to intervention group, while basic advice is given to the control group. The expected outcome should be a decrease in IGT to diabetes in intervention group and changes in prevalence of metabolic syndrome and its parameters at the end of two years," says Dr Viswanathan.

Cost of Care

The cost of diabetes care often leaves a hole in the pocket of the patient, but there was no study that documented this. Thus, a unique study was conducted to estimate the cost of medical care among hospitalised diabetic patients and to assess the influence of an additional co-morbind condition- hypertension. The study took into consideration 443 hospitalised diabetic patients. Details of cost of inpatient and out patient care and expenditure on hospitalisation for the previous two years were obtained. "The prevalence of hypertension among the study was 39.3 per cent. Prevalence of hypertension made a significant impact on expenditure pattern. On an average, a diabetic patient with hypertension spent 1.4 times more than a diabetic subject without hypertension. Median cost per hospitalisation, length of stay during admission, cost of two years on inpatient admission were all significantly higher for diabetic patients with co-morbid condition. Thus, we found that there is a need to develop a protocol on cost effective strategy for diabetes care. Strict control of hypertension should be targeted to avoid excess treatment cost on diabetes care," says Dr Tharkar.

Diabetes &TB: For a country leading in both diabetes and TB, targeting both the diseases through a joint programme, especially when both are inter-linked, is a significant step towards curbing the dual menace.

"Severe hyperglycemia interferes with TB treatment, thereby causing delay in effective management of the disease. This malaise can be addressed by training doctors and paramedics for prevention, screening and effective management of diabetes among TB patients," explains Dr Viswanathan. Keeping this in mind, the World Diabetes Foundation is funding a project 'Education and Training in prevention of diabetes for TB health personnel' at MV Hospital for Diabetes. The project, which started in February, 2009, would impart training doctors and paramedics in selected areas of Chennai, Kanchipuram and Thiruvallur. "The main purpose of the project is to develop an effective model for prevention of diabetes among TB patients and to contribute to the National TB control programme," says Dr Viswanathan.

The project is slated to train 1,000 doctors in prevention and management of diabetes, 300 paramedics on screening and diagnosis of diabetes and 300 health workers in prevention. Around 50 screening camps would be conducted for a period of three years (2009-2011).

Clinical Studies
There are various ongoing clinical studies being carried out by the department of biochemistry and genetics. Commenting on the importance of the genetics study, Dr Vijay Viswanathan, MD, MV Hospital, says, "The genetic studies being carried out are used for identifying patients who are susceptible to develop complications like kidney disease, coronary heart disease etc. We are conducting genetic studies among the offspring of patients with diabetes to find out the pattern of genetic transmission of Type 2 diabetes." On the significance of biochemical studies, he says, "The results of biochemical related studies to diabetes will make us understand the patho-physiology of the disease and to find out the matters for diagnosis purpose."

The biochemistry department is conducting a study to determine the efficacy of GA with gyclated haemoglobin among type II diabetic subjects without any complications. Some of the other on-going studies are to determine the eye changes in diabetic nephropathy using gold standards tests for diagnosis (FFA and 24-hour protienuria) and to investigate whether significant renal impairment can develop in diabetes in the absence of a history of albuminia.The department has recently completed a study to determine the level of glycated albumin (GA) among type II diabetes having diabetes nephropathy. "Studies have reported that GA is useful for the evaluation of short-term glycaemic control (two to four weeks) in patients with diabetes. It is reported that albumin turnover should change in patients with chronic renal failure having massive proteinuria, in whom GA levels should be reduced as a result of shorter exposure of plasma albumin. Hence we conducted the study of 198 subjects to asses the GA levels at different stages of diabetes nephropathy. The levels of GA were estimated using Lucia GA-L kit from Japan," says Dr Sathyavani K, Assistant Director (Research), MV Hospital.

The department of genetics is conducting a study to find out the association between monocytes chemoattractant protien (MCP-1) gene polymorphism among type 2 diabetes subjects having nephropathy in India and another study to find out ACE gene polymorphism among typ 2 diabetic subjects having renal impairment and to determine the efficacy of intervention of ACE inhibitor among patients with positive association, said Dr M Parthiban, Director of Laboratory Services, MV Hospital.

Preventing Amputation

Diabetes patients are 40 times more likely to undergo lower leg amputation. Thus a programme to prevent diabetes amputation is of utmost importance. MV Hospital for Diabetes has started a five-year project-'Diabetes Amputation Prevention Initiative In The Community'(DAPIC) from 2004. Taking two villages in the vicinity of Chennai for the study, it took population of 1,400 people all aged above 40. In one village, it is creating awareness every two months and in another the awareness was created only once.

"In a poor country like India, treating diabetes foot may account for 40 per cent of heath resources. Hence, tackling the menace by encouraging prevention of complication at the level of primary care education and GPs is the best solution,' says Dr Viswanathan.

Foot care for diabetes patients has been of special interest to Dr Viswanathan. Pained by mass amputations caused by diabetes, way back he started improvising on the footwear for diabetes. "Diabates patients had to use leprosy patient footwear and often they would be barred from entering public places as they were mistaken as leprosy patients," says Dr Viswanathan. So, Dr Viswanathan tied up with Central Leather Institute to produce cheap but customised footwear for diabetes patients. The footwear designed has no toe grip, no buckle and no steel so that diabetes amputation patients can wear them with ease.

Yoga Studies

To find out the effect of yoga to prevent/ delay on the onset of diabetes, the yoga department of the hospital is conducting a two-year study. Conducted from 2008, this study includes one group for control (standard care advice given) and another for yoga therapy and group three for LSM (diet and exercise). Subjects are motivated for diet control and physical activity, walking and yoga, during baseline visit and follow-ups. At the end of two year, the final data collection for anthropometric and biochemical details will be done. The outcome of the study will be assessed by comparing baseline and one year and two year follow-up details. Another study is planned to study the effect of yoga on newly diagnoses diabetic subjects.

Road Ahead

Despite the hospital being a successful hub for treating diabetes, there is no plan of replicating the hospital model in other cities. "Right now, we are focusing on research activities and have not planned multi-location expansion of the same scale," Dr Viswanathan explains. However, in the pipeline are diabetes OPD units at Mylapore in Chennai and at Koramangala in Bangalore.

MV Hospital is also launching 'Diastep', a footwear made of cow leather priced between Rs 1,200 to Rs 1,500. "The current diabetic footwears are not aesthetic and hence we are creating a set of footwears which would are not only fanciful but also more comfortable and safer," says Dr Viswanathan.

So, let's hope with dedicated focus on diabetes research, the increasing number of diabetic patient is curtailed to some extent.

rita.dutta@expressindia.com

 


Untitled Document
© Copyright 2001: The Indian Express Limited. All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of The Indian Express Limited. Site managed by BPD.